HARROGATE

3D Systems Receives FDA Clearance for NextDent® Base

Retrieved on: 
Wednesday, November 15, 2023
Nexus, Eye, Health Canada, RDT, NYSE, Prosthodontics, DDS, RPD, Patient, 3D Systems, FDA, Food and Drug Administration, Printing, Workflow, Heel, 3D, ROCK, Plaster, Medical device, 3D printing

NextDent Base is the third generation of the company’s denture base material for 3D printing and has excellent mechanical properties including high break resistance, and accurate and repeatable printability.

Key Points: 
  • NextDent Base is the third generation of the company’s denture base material for 3D printing and has excellent mechanical properties including high break resistance, and accurate and repeatable printability.
  • NextDent Base is truly comparable to conventional denture materials and provides patients with long-lasting, impact-resistant dentures.
  • Using NextDent Base as part of 3D Systems’ digital dental workflow is helping drive new levels of speed, productivity, efficiency, and precision while also providing opportunities to improve the patient experience.
  • “With the clearance of NextDent Base, we continue to add to our portfolio of dental 3D printing materials that are enabling dental laboratories and clinics to address a wide range of applications.

Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa

Retrieved on: 
Wednesday, September 27, 2023
Acne, Harrogate and District NHS Foundation Trust, Prevalence, Czech Republic, Glenmark, IQVIA, European Medicines Agency, XETRA, Prescription, Centralisation, Inflammation, USD, EMA, U.S. FDA, Gland, Dermatology, King Hamad University of Nursing and Associated Medical Sciences, C43, Patient, Risk, Sebaceous gland, Ageing, Research, Skin, Pharmaceutical industry, EU, Cassiopea, Clascoterone

MUMBAI, India and DUBLIN, Sept. 27, 2023 /PRNewswire/ --  Cosmo Pharmaceuticals N.V. (SIX: COPN), (XETRA: C43) ("Cosmo") and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. ("Glenmark"), today announced the signing of distribution and license agreements for Winlevi® (clascoterone cream 1%) in Europe and South Africa.

Key Points: 
  • MUMBAI, India and DUBLIN, Sept. 27, 2023 /PRNewswire/ --  Cosmo Pharmaceuticals N.V. (SIX: COPN), (XETRA: C43) ("Cosmo") and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. ("Glenmark"), today announced the signing of distribution and license agreements for Winlevi® (clascoterone cream 1%) in Europe and South Africa.
  • Alessandro Della Chà, CEO of Cosmo, said, "We are very pleased to partner with Glenmark.
  • Their strong expertise in the commercialization of pharmaceutical compounds gives us great confidence in their ability to successfully market Winlevi®.
  • Cosmo does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such statements.

Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa

Retrieved on: 
Wednesday, September 27, 2023
Acne, Harrogate and District NHS Foundation Trust, Prevalence, Czech Republic, Glenmark, IQVIA, European Medicines Agency, XETRA, Prescription, Centralisation, Inflammation, USD, EMA, U.S. FDA, Gland, Dermatology, King Hamad University of Nursing and Associated Medical Sciences, C43, Patient, Risk, Sebaceous gland, Ageing, Research, Skin, Pharmaceutical industry, EU, Cassiopea, Clascoterone

MUMBAI, India and DUBLIN, Sept. 27, 2023 /PRNewswire/ --  Cosmo Pharmaceuticals N.V. (SIX: COPN), (XETRA: C43) ("Cosmo") and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. ("Glenmark"), today announced the signing of distribution and license agreements for Winlevi® (clascoterone cream 1%) in Europe and South Africa.

Key Points: 
  • MUMBAI, India and DUBLIN, Sept. 27, 2023 /PRNewswire/ --  Cosmo Pharmaceuticals N.V. (SIX: COPN), (XETRA: C43) ("Cosmo") and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. ("Glenmark"), today announced the signing of distribution and license agreements for Winlevi® (clascoterone cream 1%) in Europe and South Africa.
  • Alessandro Della Chà, CEO of Cosmo, said, "We are very pleased to partner with Glenmark.
  • Their strong expertise in the commercialization of pharmaceutical compounds gives us great confidence in their ability to successfully market Winlevi®.
  • Cosmo does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such statements.

Neoss® Group Opens Two New Sales Offices in Europe

Retrieved on: 
Monday, December 5, 2022
Patient, Research, Biotechnology, Growth, University, Organization, Health insurance, Dentistry

ZURICH, Dec. 5, 2022 /PRNewswire/ -- Neoss Group is pleased to announce the opening of two new sales organizations, Neoss Norden AB and Neoss UK & Ireland Ltd.

Key Points: 
  • ZURICH, Dec. 5, 2022 /PRNewswire/ -- Neoss Group is pleased to announce the opening of two new sales organizations, Neoss Norden AB and Neoss UK & Ireland Ltd.
  • "These two organizations are an important foundation to be able to support our growing customer base in Europe.
  • Fernando Spieler, current National Sales Manager will be promoted to Managing Director for the newly formed Neoss UK & Ireland Ltd.
  • Neoss UK & Ireland Ltd organization is in the same building as Neoss Ltd,Windsor House, Cornwall Rd, Harrogate HG1 2PW, United Kingdom.

Neoss® Group Opens Two New Sales Offices in Europe

Retrieved on: 
Monday, December 5, 2022
Patient, Research, Biotechnology, Growth, Multimedia, University, Organization, Health insurance, Dentistry

ZURICH, Dec. 5, 2022 /PRNewswire/ -- Neoss Group is pleased to announce the opening of two new sales organizations, Neoss Norden AB and Neoss UK & Ireland Ltd.

Key Points: 
  • ZURICH, Dec. 5, 2022 /PRNewswire/ -- Neoss Group is pleased to announce the opening of two new sales organizations, Neoss Norden AB and Neoss UK & Ireland Ltd.
  • "These two organizations are an important foundation to be able to support our growing customer base in Europe.
  • Fernando Spieler, current National Sales Manager will be promoted to Managing Director for the newly formed Neoss UK & Ireland Ltd.
  • Neoss UK & Ireland Ltd organization is in the same building as Neoss Ltd,Windsor House, Cornwall Rd, Harrogate HG1 2PW, United Kingdom.

Top Spec Cleaning & Maintenance Ltd Opens for Business, Offering Professional Cleaning Services

Retrieved on: 
Friday, July 29, 2022
TLC, Cooking, Mark (given name), Restaurant, Glass, GLOBE, Top, Wood drying, Video game, Maintenance

Based in Yorkshire, Top Spec Cleaning & Maintenance Ltd is a professional, trusted cleaning company that offers both domestic and commercial cleaning services, specialising in oven cleaning and repairs.

Key Points: 
  • Based in Yorkshire, Top Spec Cleaning & Maintenance Ltd is a professional, trusted cleaning company that offers both domestic and commercial cleaning services, specialising in oven cleaning and repairs.
  • If youre searching for oven cleaning York services, look no further than Top Spec Cleaning & Maintenance.
  • Top Spec Cleaning & Maintenance can make your home or workspace truly shine, and the team takes great pride in their work.
  • Top Specs professional oven cleaning services are carried out by fully trained oven cleaning Harrogate experts who can deep clean a wide variety of cooking appliances, including:

One Heritage Group plc: Acquisition of Development Land on Victoria Road, Eccleshill, West Yorkshire

Retrieved on: 
Tuesday, July 12, 2022
Housing, Acquisition, Yorkshire Dales, Heritage, CEO, MAR, LSE, Victoria Road, Tunnel, Eccleshill, EU, England (disambiguation)

One Heritage Group plc: Acquisition of Development Land on Victoria Road, Eccleshill, West Yorkshire

Key Points: 
  • One Heritage Group plc: Acquisition of Development Land on Victoria Road, Eccleshill, West Yorkshire
    Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.
  • Acquisition of Development Land on Victoria Road, Eccleshill, West Yorkshire
    One Heritage Group PLC (LSE: OHG), the UK-based residential developer focused on the North of England, is pleased to announce that it has completed the acquisition of development land on Victoria Road, Eccleshill, West Yorkshire ("Victoria Road") for 1,000,000.
  • The land on Victoria Road was previously used for industrial purposes and all buildings have been fully demolished.
  • Jason Upton, CEO of One Heritage Group commented: "I am delighted that we have secured this development land in Eccleshill which will be our first new build housing development.

FinancialForce Partners with Talent Works to Source Engineering Talent in EMEA and Enhance Employer Brand

Retrieved on: 
Monday, February 7, 2022
Finance, Communications, Professional Services, Other Communications, Human Resources, Talent, SVP, Fresh Talent – Working in Scotland Scheme, FinancialForce.com, EMEA, Program, Technology, RPO, Acquisition, Creative industries, Public relations

Headquartered in San Francisco, California, with EMEA headquarters in Harrogate, England, FinancialForce chose Talent Works to support its overseas hiring targets.

Key Points: 
  • Headquartered in San Francisco, California, with EMEA headquarters in Harrogate, England, FinancialForce chose Talent Works to support its overseas hiring targets.
  • Support provided by Boston-based Talent Works SVP, Jody Robie, the Talent Works team has built a digital recruitment marketing campaign targeted specifically to Software Developer candidates that helps to differentiate FinancialForce by communicating innovation messages to technical applicants.
  • At FinancialForce we recognize the need to outsource our efforts to ensure we are able to reach the right talent.
  • The consultative approach of Talent Works has been invaluable, working with us to produce the best outcome for our team in the UK.

Amedisys Honors 37 Employees with Annual Spirit of Excellence Award

Retrieved on: 
Wednesday, January 26, 2022
Linda, Physician, Hospice, Rehabilitation, BATON, Heart, Conditional sentence, Volunteering, NASDAQ, Palliative care, Company, Home health, Hospital, Clinical Excellence Awards, Patient, District, GLOBE, Medicine, Healthcare, Residential care, Amedisys

BATON ROUGE, La., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, has recognized 37 employees with the prestigious Spirit of Excellence Awards, one of the companys highest honors.

Key Points: 
  • BATON ROUGE, La., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, has recognized 37 employees with the prestigious Spirit of Excellence Awards, one of the companys highest honors.
  • The 37 winners were named from our roster of more than 21,000 employees nationwide.
  • Winners demonstrate clinical excellence with patients, positively influence patients and their families, achieve at a level beyond typical duties and promote patient independence.
  • Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high acuity care services.

Neoss brings you Integrate 2022 - A celebration of 20 years of Intelligent Simplicity.

Retrieved on: 
Thursday, January 27, 2022
Research, Yoga, CEO, Risk, Health, Digital, Simplicity, Solution, Accuracy and precision, Patient, Multimedia

WOODLAND HILLS, Calif., Jan. 27, 2022 /PRNewswire/ -- This summer, Neoss is celebrating 20 years of Intelligent Simplicity and is inviting the dental community from around the globe to attend an exceptional scientific program.

Key Points: 
  • WOODLAND HILLS, Calif., Jan. 27, 2022 /PRNewswire/ -- This summer, Neoss is celebrating 20 years of Intelligent Simplicity and is inviting the dental community from around the globe to attend an exceptional scientific program.
  • The program lectures and break-out sessions will showcase how you can bring efficient workflows into your daily practice.
  • All to celebrate the valued community Neoss has created over its 20 years of innovation.
  • In developing smart treatment solutions and working closely with each practice, Neoss makes the complex less complicated.